Safety and Business Impact Response to COVID-19
First written in FY2020. 3 of 7 entries say "Restated". Latest entry: FY2023.
The whole theme swung hardest in 2026: 1 of 12 companies on the "Worse" side.
18 other companies' latest entry also says "Dropped".
- FY2023DroppedAnnual report
「During the current consolidated fiscal year, restrictions on activities in response to COVID-19 were gradually eased in Japan and worldwide, and the normalization of social and economic activity made steady progress.」
The measures addressing COVID-19 that had specifically described the resumption of operations at all plants and the recovery of production and sales were not continued in this filing and have been replaced by a description of economic normalization. - FY2022-Q2RestatedAnnual report
「Regarding the impact of the spread of COVID-19, production and sales declined in fiscal 2019 due to temporary production stoppages, but all plants had resumed operations by the end of June 2020, and production and sales were recovering.」
The Company continues to report that all plants have resumed operations and that production and sales are recovering. - FY2022-Q1RestatedAnnual report
「Regarding the impact of the spread of COVID-19, production and sales declined in fiscal 2019 due to temporary production stoppages, but all plants had resumed operations by the end of June 2020, and production and sales were recovering.」
Regarding the response to COVID-19, the Company continues to report that all plants have resumed operations and that production and sales are recovering. - FY2021-Q3RestatedAnnual report
「Regarding the effects of the spread of the novel coronavirus, production and sales had declined due to temporary suspensions of operations, but as of the end of June 2020, all plants had resumed operations and production and sales were showing signs of recovery.」
The Company continues to report that all plants have resumed operations and that production and sales are recovering, with no substantive change in the specific content from the previous quarter. - FY2021-Q2AdvancedAnnual report
「Regarding the effects of the spread of the novel coronavirus, production and sales had declined due to temporary suspensions of operations, but as of the end of June 2020, all plants had resumed operations and production and sales were showing signs of recovery.」
Regarding the response to COVID-19, the Company showed specific progress, stating that production and sales were recovering following the resumption of operations at all plants. - FY2021-Q1AdvancedAnnual report
「Regarding the effects of the spread of the novel coronavirus, production and sales had declined due to temporary suspensions of operations, but as of the end of June 2020, all plants had resumed operations.」
Regarding the response to COVID-19, the Company showed specific progress, with all plants resuming operations by the end of June 2020 following temporary plant closures. - FY2020First statedAnnual report
「We will implement measures that place the safety and health of all stakeholders and employees first. If the impact of COVID-19 is prolonged, it is expected to have a significant effect on the Group's overall business operations and performance. Although the effects of force majeure cannot be prevented or mitigated, we will proactively work to minimize the impacts that can be addressed.」
The Company explicitly stated for the first time that it would prioritize safety and health measures in response to COVID-19 and work to minimize impacts that can be addressed.